Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated

BIOLOGICAL2 trials

Sponsors

Sinovac Research and Development Co., Ltd., Sinovac Life Sciences Co., Ltd.

Conditions

COVID-19

Phase 2

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

SuspendedNCT05150496

Sinovac Research and Development Co., Ltd.COVID-19

Start: 2022-12-15End: 2023-01-15Target: 640Updated: 2022-08-11

Phase 4

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

CompletedNCT05165966

Sinovac Life Sciences Co., Ltd.COVID-19

Start: 2021-10-20End: 2022-07-01Updated: 2022-08-11